Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomas.

Gild ML, Naik N, Hoang J, Hsiao E, McGrath RT, Sywak M, Sidhu S, Delbridge LW, Robinson BG, Schembri G, Clifton-Bligh RJ.

Clin Endocrinol (Oxf). 2018 May 9. doi: 10.1111/cen.13737. [Epub ahead of print]

PMID:
29741215
2.

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.

Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, Sioson L, Clarkson A, Sheen A, Luxford C, Elston MS, Meyer-Rochow GY, Nano MT, Kruijff S, Engelsman AF, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Marsh DJ, Toon CW, Chou A, Clifton-Bligh RJ.

Am J Surg Pathol. 2018 Jan 10. doi: 10.1097/PAS.0000000000001017. [Epub ahead of print]

PMID:
29324469
3.

Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors.

Robinson BG, Condon AF, Radl D, Borrelli E, Williams JT, Neve KA.

Elife. 2017 Nov 20;6. pii: e31924. doi: 10.7554/eLife.31924.

4.

Clinical guidance for radioiodine refractory differentiated thyroid cancer.

Gild ML, Topliss DJ, Learoyd D, Parnis F, Tie J, Hughes B, Walsh JP, McLeod DSA, Clifton-Bligh RJ, Robinson BG.

Clin Endocrinol (Oxf). 2018 Apr;88(4):529-537. doi: 10.1111/cen.13508. Epub 2017 Nov 24. Review.

PMID:
29095527
5.

TERT structural rearrangements in metastatic pheochromocytomas.

Dwight T, Flynn A, Amarasinghe K, Benn DE, Lupat R, Li J, Cameron DL, Hogg A, Balachander S, Candiloro ILM, Wong SQ, Robinson BG, Papenfuss AT, Gill AJ, Dobrovic A, Hicks RJ, Clifton-Bligh RJ, Tothill RW.

Endocr Relat Cancer. 2018 Jan;25(1):1-9. doi: 10.1530/ERC-17-0306. Epub 2017 Oct 3.

PMID:
28974544
6.

Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.

Dwight T, Na U, Kim E, Zhu Y, Richardson AL, Robinson BG, Tucker KM, Gill AJ, Benn DE, Clifton-Bligh RJ, Winge DR.

BMC Cancer. 2017 Jul 24;17(1):497. doi: 10.1186/s12885-017-3486-z.

7.

Desensitized D2 autoreceptors are resistant to trafficking.

Robinson BG, Bunzow JR, Grimm JB, Lavis LD, Dudman JT, Brown J, Neve KA, Williams JT.

Sci Rep. 2017 Jun 29;7(1):4379. doi: 10.1038/s41598-017-04728-z.

8.

ACTH-secreting medullary thyroid cancer: a case series.

Wijewardene AA, Glastras SJ, Learoyd DL, Robinson BG, Tsang VHM.

Endocrinol Diabetes Metab Case Rep. 2017 May 17;2017. pii: 16-0110. doi: 10.1530/EDM-16-0110. eCollection 2017.

9.

Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.

Mathiesen JS, Habra MA, Bassett JHD, Choudhury SM, Balasubramanian SP, Howlett TA, Robinson BG, Gimenez-Roqueplo AP, Castinetti F, Vestergaard P, Frank-Raue K.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2069-2074. doi: 10.1210/jc.2016-3640.

10.

The lateral line confers evolutionarily derived sleep loss in the Mexican cavefish.

Jaggard J, Robinson BG, Stahl BA, Oh I, Masek P, Yoshizawa M, Keene AC.

J Exp Biol. 2017 Jan 15;220(Pt 2):284-293. doi: 10.1242/jeb.145128.

11.

Professor Solomon Posen, MD, FRACP, FRCP: 1924-2016-Physician, Scientist, Mentor.

Robinson BG, Clifton-Bligh PB, Mason RS.

J Bone Miner Res. 2016 Nov;31(11):1915-1916. doi: 10.1002/jbmr.2911. Epub 2016 Oct 20. No abstract available.

12.

NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.

Reagh J, Bullock M, Andrici J, Turchini J, Sioson L, Clarkson A, Watson N, Sheen A, Lim G, Delbridge L, Sidhu S, Sywak M, Aniss A, Shepherd P, Ng D, Oei P, Field M, Learoyd D, Robinson BG, Clifton-Bligh RJ, Gill AJ.

Am J Surg Pathol. 2017 Jan;41(1):75-81.

PMID:
27635947
13.

The safety of vandetanib for the treatment of thyroid cancer.

Tsang VH, Robinson BG, Learoyd DL.

Expert Opin Drug Saf. 2016 Aug;15(8):1107-13. doi: 10.1080/14740338.2016.1201060. Epub 2016 Jul 4. Review.

PMID:
27301016
14.

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.

Bullock M, Ren Y, O'Neill C, Gill A, Aniss A, Sywak M, Sidhu S, Delbridge L, Learoyd D, de Vathaire F, Robinson BG, Clifton-Bligh RJ.

Clin Endocrinol (Oxf). 2016 Aug;85(2):283-90. doi: 10.1111/cen.12999. Epub 2016 Feb 8.

15.

Destabilizing RET in targeted treatment of thyroid cancers.

Gild ML, Bullock M, Pon CK, Robinson BG, Clifton-Bligh RJ.

Endocr Connect. 2016 Jan;5(1):10-9. doi: 10.1530/EC-15-0098. Epub 2015 Nov 16.

16.

Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.

Tsang VH, Tacon LJ, Learoyd DL, Robinson BG.

Recent Results Cancer Res. 2015;204:157-78. doi: 10.1007/978-3-319-22542-5_7. Review.

PMID:
26494388
17.

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.

Glover AR, Zhao JT, Gill AJ, Weiss J, Mugridge N, Kim E, Feeney AL, Ip JC, Reid G, Clarke S, Soon PS, Robinson BG, Brahmbhatt H, MacDiarmid JA, Sidhu SB.

Oncotarget. 2015 Nov 3;6(34):36675-88. doi: 10.18632/oncotarget.5383.

18.

Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium.

Gantz SC, Robinson BG, Buck DC, Bunzow JR, Neve RL, Williams JT, Neve KA.

Elife. 2015 Aug 26;4. doi: 10.7554/eLife.09358.

19.

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.

Benn DE, Robinson BG, Clifton-Bligh RJ.

Endocr Relat Cancer. 2015 Aug;22(4):T91-103. doi: 10.1530/ERC-15-0268. Review.

20.

Structural and functional consequences of succinate dehydrogenase subunit B mutations.

Kim E, Rath EM, Tsang VH, Duff AP, Robinson BG, Church WB, Benn DE, Dwight T, Clifton-Bligh RJ.

Endocr Relat Cancer. 2015 Jun;22(3):387-97. doi: 10.1530/ERC-15-0099.

21.

Distinct genetic architecture underlies the emergence of sleep loss and prey-seeking behavior in the Mexican cavefish.

Yoshizawa M, Robinson BG, Duboué ER, Masek P, Jaggard JB, O'Quin KE, Borowsky RL, Jeffery WR, Keene AC.

BMC Biol. 2015 Feb 20;13:15. doi: 10.1186/s12915-015-0119-3.

22.

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Ip JC, Pang TC, Glover AR, Soon P, Zhao JT, Clarke S, Robinson BG, Gill AJ, Sidhu SB.

Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.

23.

Mortality associated with primary hyperparathyroidism.

Clifton-Bligh PB, Nery ML, Supramaniam R, Reeve TS, Delbridge L, Stiel JN, McElduff A, Wilmshurst EG, Robinson BG, Fulcher GR, Learoyd D, Posen S.

Bone. 2015 May;74:121-4. doi: 10.1016/j.bone.2014.12.067. Epub 2015 Jan 27.

PMID:
25637062
24.

Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence.

Glover AR, Zhao JT, Ip JC, Lee JC, Robinson BG, Gill AJ, Soon PS, Sidhu SB.

Endocr Relat Cancer. 2015 Feb;22(1):99-109. doi: 10.1530/ERC-14-0457.

25.

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

Chou A, Fraser S, Toon CW, Clarkson A, Sioson L, Farzin M, Cussigh C, Aniss A, O'Neill C, Watson N, Clifton-Bligh RJ, Learoyd DL, Robinson BG, Selinger CI, Delbridge LW, Sidhu SB, O'Toole SA, Sywak M, Gill AJ.

Am J Surg Pathol. 2015 May;39(5):652-9. doi: 10.1097/PAS.0000000000000368.

26.

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer.

Gundara JS, Zhao J, Gill AJ, Lee JC, Delbridge L, Robinson BG, McLean C, Serpell J, Sidhu SB.

Cancer Med. 2015 Feb;4(2):174-82. doi: 10.1002/cam4.355. Epub 2014 Dec 8.

27.

Improving Outcomes in Adrenocortical Cancer: An Australian Perspective.

Ip JC, Pang TC, Glover AR, Soon P, Clarke S, Richardson A, Campbell P, Robinson BG, Sidhu SB.

Ann Surg Oncol. 2015 Jul;22(7):2309-16. doi: 10.1245/s10434-014-4133-4. Epub 2014 Oct 16.

PMID:
25319576
28.

Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

Gill AJ, Hes O, Papathomas T, Šedivcová M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills K, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EP, van Leenders GJ, Przybycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov K.

Am J Surg Pathol. 2014 Dec;38(12):1588-602. doi: 10.1097/PAS.0000000000000292.

29.

The influence of weather and lemmings on spatiotemporal variation in the abundance of multiple avian guilds in the arctic.

Robinson BG, Franke A, Derocher AE.

PLoS One. 2014 Jul 1;9(7):e101495. doi: 10.1371/journal.pone.0101495. eCollection 2014.

30.

Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.

Matsui A, Jarvie BC, Robinson BG, Hentges ST, Williams JT.

Neuron. 2014 Jun 18;82(6):1346-56. doi: 10.1016/j.neuron.2014.04.030. Epub 2014 May 22.

31.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

Hamilton A, Newby PR, Carr-Smith JD, Disanto G, Allahabadia A, Armitage M, Brix TH, Chatterjee K, Connell JM, Hegedüs L, Hunt PJ, Lazarus JH, Pearce SH, Robinson BG, Taylor JC, Vaidya B, Wass JA, Wiersinga WM, Weetman AP, Ramagopalan SV, Franklyn JA, Gough SC, Simmonds MJ.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1459-65. doi: 10.1210/jc.2014-1270. Epub 2014 May 19.

PMID:
24840812
32.

Succinate dehydrogenase subunit D and succinate dehydrogenase subunit B mutation analysis in canine phaeochromocytoma and paraganglioma.

Holt DE, Henthorn P, Howell VM, Robinson BG, Benn DE.

J Comp Pathol. 2014 Jul;151(1):25-34. doi: 10.1016/j.jcpa.2014.03.007. Epub 2014 Mar 27.

PMID:
24813157
33.

Pituitary metastasis from breast cancer presenting as diabetes insipidus.

Gormally JF, Izard MA, Robinson BG, Boyle FM.

BMJ Case Rep. 2014 Apr 12;2014. pii: bcr2014203683. doi: 10.1136/bcr-2014-203683.

34.

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.

Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PSh.

BMC Cancer. 2014 Mar 18;14:200. doi: 10.1186/1471-2407-14-200.

35.

Succinate dehydrogenase deficiency is rare in pituitary adenomas.

Gill AJ, Toon CW, Clarkson A, Sioson L, Chou A, Winship I, Robinson BG, Benn DE, Clifton-Bligh RJ, Dwight T.

Am J Surg Pathol. 2014 Apr;38(4):560-6. doi: 10.1097/PAS.0000000000000149.

36.

Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.

Tsang VH, Dwight T, Benn DE, Meyer-Rochow GY, Gill AJ, Sywak M, Sidhu S, Veivers D, Sue CM, Robinson BG, Clifton-Bligh RJ, Parker NR.

Endocr Relat Cancer. 2014 May 6;21(3):415-26. doi: 10.1530/ERC-13-0519. Print 2014 Jun.

37.

MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB.

Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.

38.

The role of Cdk5 in neuroendocrine thyroid cancer.

Pozo K, Castro-Rivera E, Tan C, Plattner F, Schwach G, Siegl V, Meyer D, Guo A, Gundara J, Mettlach G, Richer E, Guevara JA, Ning L, Gupta A, Hao G, Tsai LH, Sun X, Antich P, Sidhu S, Robinson BG, Chen H, Nwariaku FE, Pfragner R, Richardson JA, Bibb JA.

Cancer Cell. 2013 Oct 14;24(4):499-511. doi: 10.1016/j.ccr.2013.08.027.

39.

Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.

McInerney-Leo AM, Marshall MS, Gardiner B, Benn DE, McFarlane J, Robinson BG, Brown MA, Leo PJ, Clifton-Bligh RJ, Duncan EL.

Clin Endocrinol (Oxf). 2014 Jan;80(1):25-33. doi: 10.1111/cen.12331. Epub 2013 Oct 25.

PMID:
24102379
40.

The medical workforce of the future.

Robinson BG, Brooks PM.

Med J Aust. 2013 Sep 2;199(5 Suppl):S3-5. No abstract available.

PMID:
25370091
41.

Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor.

Ghayee HK, Bhagwandin VJ, Stastny V, Click A, Ding LH, Mizrachi D, Zou YS, Chari R, Lam WL, Bachoo RM, Smith AL, Story MD, Sidhu S, Robinson BG, Nwariaku FE, Gazdar AF, Auchus RJ, Shay JW.

PLoS One. 2013 Jun 13;8(6):e65624. doi: 10.1371/journal.pone.0065624. Print 2013.

42.

Current management options for recurrent adrenocortical carcinoma.

Glover AR, Ip JC, Zhao JT, Soon PS, Robinson BG, Sidhu SB.

Onco Targets Ther. 2013 Jun 6;6:635-43. doi: 10.2147/OTT.S34956. Print 2013.

43.

Drosophila larvae as a model to study physiological alcohol dependence.

Robinson BG, Khurana S, Atkinson NS.

Commun Integr Biol. 2013 Mar 1;6(2):e23501. doi: 10.4161/cib.23501.

44.

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Wells SA Jr, Pacini F, Robinson BG, Santoro M.

J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6. Review.

45.

Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.

Dwight T, Mann K, Benn DE, Robinson BG, McKelvie P, Gill AJ, Winship I, Clifton-Bligh RJ.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1103-8. doi: 10.1210/jc.2013-1400. Epub 2013 Apr 30.

PMID:
23633203
46.

Is alcoholism learned? Insights from the fruit fly.

Robinson BG, Atkinson NS.

Curr Opin Neurobiol. 2013 Aug;23(4):529-34. doi: 10.1016/j.conb.2013.01.016. Epub 2013 Feb 22.

47.

Neural adaptation leads to cognitive ethanol dependence.

Robinson BG, Khurana S, Kuperman A, Atkinson NS.

Curr Biol. 2012 Dec 18;22(24):2338-41. doi: 10.1016/j.cub.2012.10.038. Epub 2012 Nov 29.

48.

Oncophagy: harnessing regulation of autophagy in cancer therapy.

Gundara JS, Zhao J, Robinson BG, Sidhu SB.

Endocr Relat Cancer. 2012 Nov 19;19(6):R281-95. doi: 10.1530/ERC-12-0325. Print 2012 Dec. Review.

49.

Nodal metastasis microRNA expression correlates with the primary tumour in MTC.

Gundara JS, Zhao JT, Gill AJ, Clifton-Bligh R, Robinson BG, Delbridge L, Sidhu SB.

ANZ J Surg. 2014 Apr;84(4):235-9. doi: 10.1111/j.1445-2197.2012.06291.x. Epub 2012 Oct 16.

PMID:
23072640
50.

Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ.

Am J Surg Pathol. 2013 Feb;37(2):226-33. doi: 10.1097/PAS.0b013e3182671155.

PMID:
23060355

Supplemental Content

Loading ...
Support Center